促销时间表 ABIVAX Société Anonyme
先进的时间表
简单图表
关于公司
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
| EBITDA |
-0.0333 |
| EV/EBITDA |
-0.3297 |
| IPO date |
2023-10-20 |
| ISIN |
US00370M1036 |
| Industry |
Biotechnology |
| P/BV |
2.13 |
| P/S |
90.21 |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
eur |
| Выручка |
2.3E-5 |
| Сайт |
https://www.abivax.com
|
| Цена ао |
10.29 |
| Число акций ао |
0.04307 млрд |
| 每日价格变化: |
-5.54% (10.29) |
| 每周价格变化: |
-16.21% (11.6) |
| 每月价格变化: |
-21.3% (12.35) |
| 3个月内价格变化: |
-26.59% (13.24) |
| 六个月内的价格变化: |
-36.84% (15.39) |
| 年初以来价格变化: |
+7.4% (9.05) |
|
|
低估
| 姓名 |
意义 |
年级 |
| P/S |
90.21 |
1 |
| P/BV |
2.13 |
7 |
| P/E |
0 |
0 |
| EV/EBITDA |
-1.68 |
0 |
| 全部的: |
|
3.88 |
|
效率
| 姓名 |
意义 |
年级 |
| ROA, % |
-45.17 |
0 |
| ROE, % |
-75.37 |
0 |
| 全部的: |
|
0 |
|
|
|
股息
| 姓名 |
意义 |
年级 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 全部的: |
|
0 |
|
责任
| 姓名 |
意义 |
年级 |
| Debt/EBITDA |
-0.4212 |
10 |
| 全部的: |
|
9.6 |
|
成长冲动
| 姓名 |
意义 |
年级 |
| 盈利能力 Revenue, % |
19991.3 |
10 |
| 盈利能力 Ebitda, % |
294.32 |
10 |
| 盈利能力 EPS, % |
-50.72 |
0 |
| 全部的: |
|
8 |
|
| 导师 |
职称 |
支付 |
出生年份 |
| Dr. Philippe Pouletty M.D., Ph.D. |
Founder & Director |
N/A |
1958 (66 年) |
| Mr. Marc M. P. de Garidel M.B.A. |
CEO & Director |
858.61k |
1958 (66 年) |
| Mr. Didier Blondel |
EVP, CFO & Board Secretary |
N/A |
1964 (60 年) |
| Mr. Didier Scherrer Ph.D. |
Chief Scientific Officer |
N/A |
1970 (54 年) |
| Mr. Patrick Malloy |
Senior Vice President of Investor Relations |
N/A |
|
| Ms. Ida Hatoum |
Chief People & Compliance Officer |
N/A |
1975 (49 年) |
| Mr. Pierre Courteille M.B.A. |
Chief Business Officer |
N/A |
1969 (55 年) |
| Mr. Michael Ferguson B.S., M.B.A. |
Chief Commercial Officer |
N/A |
1978 (46 年) |
| Mr. Jerome Denis Ph.D. |
Executive Vice President of Process Development & Manufacturing |
|
|
| Ms. Ana Sharma M.P.H. |
VP & Global Head of Quality |
|
|
